Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 1
2011 2
2012 2
2013 3
2014 1
2015 4
2016 9
2017 5
2018 8
2019 6
2020 5
2021 16
2022 12
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of pemafibrate in patients with hypertriglyceridemia in clinical settings: A retrospective study.
Katakura Y, Shimoda M, Ohnishi M, Kusano T, Dan K, Isobe H, Wamata R, Iwamoto Y, Fushimi Y, Sanada J, Obata A, Kimura T, Tatsumi F, Nakanishi S, Mune T, Kaku K, Kaneto H. Katakura Y, et al. Among authors: tatsumi f. Nutr Metab Cardiovasc Dis. 2023 Jul;33(7):1444-1452. doi: 10.1016/j.numecd.2023.02.011. Epub 2023 Feb 21. Nutr Metab Cardiovasc Dis. 2023. PMID: 37246074 Free article.
Persistent Hypoglycemia Induced by Long-acting Insulin Degludec.
Katakura Y, Tatsumi F, Kusano T, Shimoda M, Kohara K, Kimura T, Obata A, Nakanishi S, Mune T, Kaku K, Kaneto H. Katakura Y, et al. Among authors: tatsumi f. Intern Med. 2022 Mar 15;61(6):861-864. doi: 10.2169/internalmedicine.7915-21. Epub 2021 Sep 4. Intern Med. 2022. PMID: 34483209 Free PMC article.
Comparison of clinical efficacy and safety of weekly glucagon-like peptide-1 receptor agonists dulaglutide and semaglutide in Japanese patients with type 2 diabetes: Randomized, parallel-group, multicentre, open-label trial (COMING study).
Kimura T, Katakura Y, Shimoda M, Kawasaki F, Yamabe M, Tatsumi F, Matsuki M, Iwamoto Y, Anno T, Fushimi Y, Kamei S, Kimura Y, Nakanishi S, Mune T, Kaku K, Kaneto H; COMING study Group. Kimura T, et al. Among authors: tatsumi f. Diabetes Obes Metab. 2023 Dec;25(12):3632-3647. doi: 10.1111/dom.15258. Epub 2023 Aug 30. Diabetes Obes Metab. 2023. PMID: 37646192 Clinical Trial.
Correlation of Baba's diabetic neuropathy classification with various diabetes-related complications.
Iwamoto Y, Nakanishi S, Itoh T, Nakao E, Sugisaki T, Kusano T, Ohnishi M, Takenouchi H, Iwamoto H, Sanada J, Fushimi Y, Katakura Y, Hemmi S, Kimura T, Tatsumi F, Shimoda M, Mune T, Kaku K, Kaneto H. Iwamoto Y, et al. Among authors: tatsumi f. Front Endocrinol (Lausanne). 2022 Oct 27;13:1054934. doi: 10.3389/fendo.2022.1054934. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36387868 Free PMC article.
Temporal lobe epilepsy associated with GAD autoimmunity.
Obata A, Kutoku Y, Sunada Y, Okauchi S, Kimura T, Hirukawa H, Tanabe A, Kinoshita T, Kohara K, Tatsumi F, Shimoda M, Kamei S, Nakanishi S, Mune T, Kaku K, Kaneto H. Obata A, et al. Among authors: tatsumi f. Acta Diabetol. 2017 Mar;54(3):321-323. doi: 10.1007/s00592-016-0910-9. Epub 2016 Sep 8. Acta Diabetol. 2017. PMID: 27638303 Free PMC article. No abstract available.
Usefulness of Once-Weekly GLP-1 Receptor Agonist Semaglutide on Glycemic Control in Subjects with Type 2 Diabetes Mellitus: Switching from the Same Class Dulaglutide in a Retrospective Observation Study.
Kimura T, Kubo M, Takahashi K, Wamata R, Iwamoto Y, Iwamoto H, Katakura Y, Sanada J, Fushimi Y, Shimoda M, Tatsumi F, Nakanishi S, Mune T, Kaku K, Kaneto H. Kimura T, et al. Among authors: tatsumi f. J Diabetes Res. 2024 Jan 4;2024:5880589. doi: 10.1155/2024/5880589. eCollection 2024. J Diabetes Res. 2024. PMID: 38223524 Free PMC article.
Effect of Hyperglycemia-Related Acute Metabolic Disturbance on Thyroid Function Parameters in Adults.
Iwamoto Y, Kimura T, Tatsumi F, Sugisaki T, Kubo M, Nakao E, Dan K, Wamata R, Iwamoto H, Takahashi K, Sanada J, Fushimi Y, Katakura Y, Shimoda M, Nakanishi S, Mune T, Kaku K, Kaneto H. Iwamoto Y, et al. Among authors: tatsumi f. Front Endocrinol (Lausanne). 2022 May 12;13:869869. doi: 10.3389/fendo.2022.869869. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35634497 Free PMC article.
Clinical findings of acute necrotizing esophagitis complicated by diabetic ketoacidosis.
Iwamoto Y, Kimura T, Itoh T, Mori S, Sasaki T, Ohnishi M, Takenouchi H, Iwamoto H, Sanada J, Fushimi Y, Katakura Y, Tatsumi F, Shimoda M, Nakanishi S, Mune T, Kaku K, Kaneto H. Iwamoto Y, et al. Among authors: tatsumi f. Endocr J. 2024 Mar 7. doi: 10.1507/endocrj.EJ23-0516. Online ahead of print. Endocr J. 2024. PMID: 38447977 Free article.
Glucagon Test Is a Useful Predictor of Withdrawal From Insulin Therapy in Subjects With Type 2 Diabetes Mellitus.
Iwamoto Y, Kimura T, Tatsumi F, Sugisaki T, Kubo M, Nakao E, Dan K, Wamata R, Iwamoto H, Takahashi K, Sanada J, Fushimi Y, Katakura Y, Shimoda M, Nakanishi S, Mune T, Kaku K, Kaneto H. Iwamoto Y, et al. Among authors: tatsumi f. Front Endocrinol (Lausanne). 2022 Apr 28;13:871660. doi: 10.3389/fendo.2022.871660. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35574023 Free PMC article.
77 results